Immunosuppressants Sirolimus (Rapamycin) for SLE: Phase 3 SIRIUS Trial Shows Efficacy | EULAR 2026 🩺 Rheumatology • SLE • Clinical Trial • EULAR 2026 Randomized Trial Supports ... Dr. Tina Sugandh Posted on June 12, 2026 Continue Reading
Immunosuppressants Rapacan (Sirolimus) — Biocon • Product Overview, Dosing & Safety 🧾 Product Overview Table Brand NameRapacanGeneric Name (Active Ingredient)Sirolimus (rapamycin)StrengthsTypical strengths: 1 mg, 2 mg (varies by region)Dosage FormOral tablets / oral solution (market dependent)ManufacturerBiocon ... Dr. Tina Sugandh Posted on September 29, 2025 Continue Reading